NanoViricides
NNVC
#10528
Rank
โ‚ฌ32.46 M
Marketcap
1,27ย โ‚ฌ
Share price
5.93%
Change (1 day)
-27.88%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -0,39ย โ‚ฌ

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -0,39ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,56ย โ‚ฌ an increase over its 2024 EPS that were of -0,62ย โ‚ฌ.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,39ย โ‚ฌ-31.06%
2025-0,56ย โ‚ฌ-10%
2024-0,62ย โ‚ฌ-5.41%
2023-0,66ย โ‚ฌ5.71%
2022-0,62ย โ‚ฌ-13.58%
2021-0,72ย โ‚ฌ-66.11%
2020-2,12ย โ‚ฌ1.7%
2019-2,09ย โ‚ฌ-10.98%
2018-2,35ย โ‚ฌ-22.35%
2017-3,02ย โ‚ฌ-10.53%
2016-3,38ย โ‚ฌ375%
2015-0,71ย โ‚ฌ-85.19%
2014-4,80ย โ‚ฌ42.11%
2013-3,38ย โ‚ฌ26.67%
2012-2,67ย โ‚ฌ-6.25%
2011-2,84ย โ‚ฌ14.28%
2010-2,49ย โ‚ฌ100%
2009-1,24ย โ‚ฌ-0%
2008-1,24ย โ‚ฌ-33.33%
2007-1,87ย โ‚ฌ-0%
2006-1,87ย โ‚ฌ4445.07%
2005-0,04107ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-2,31ย โ‚ฌ 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
1,12ย โ‚ฌ-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,04ย โ‚ฌ-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,84ย โ‚ฌ-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-1,35ย โ‚ฌ 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,28ย โ‚ฌ 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA